Funds holding TENAYA THERAPEUTICS INC
ISIN US87990A1060 · United States
- Fund holders
- 20
- Of which ETFs
- 4 16 other funds
- Value held
- ≈ 8.2M $ 8.1M $ · 90.5K €
- Share of capital
- 4.8 % of 224.2M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5,136,220 | 3.8M $ | 0.00 % | 2.29 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,768,551 | 1.3M $ | 0.00 % | 0.79 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,490,588 | 1.1M $ | 0.01 % | 0.66 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 824,295 | 716.3K $ | 0.00 % | 0.37 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 303,128 | 263.4K $ | 0.00 % | 0.14 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 231,319 | 201K $ | 0.00 % | 0.10 % | as of May 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 221,893 | 164.3K $ | 0.01 % | 0.10 % | as of Jul 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 175,000 | 129.3K $ | 0.09 % | 0.08 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 161,857 | 119.6K $ | 0.00 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 120,429 | 104.7K $ | 0.00 % | 0.05 % | as of May 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 113,232 | 83.7K $ | 0.00 % | 0.05 % | as of Jun 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 83,260 | 61.5K $ | 0.00 % | 0.04 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Total Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 31,453 | 23.2K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 24,395 | 18.1K $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 11,421 | 9.9K $ | 0.01 % | 0.01 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 8,012 | 7K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 4,770 | 3.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 3,852 | 2.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 3,673 | 3.2K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 90.5K € | 0.11 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.11 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.09 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.01 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.01 % | as of May 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.01 % | as of Jul 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 19 | -2 | 10,717,348 | -3.7 % |
| 2026Q2 | 21 | +3 | 11,132,372 | +8.9 % |
| 2026Q1 | 18 | +2 | 10,226,719 | +89.6 % |
| 2025Q4 | 16 | -29 | 5,393,624 | -15.0 % |
| 2025Q3 | 45 | -45 | 6,347,755 | -38.7 % |
| 2025Q2 | 90 | -24 | 10,359,913 | -23.2 % |
| 2025Q1 | 114 | +5 | 13,485,223 | +16.8 % |
| 2024Q4 | 109 | -4 | 11,547,740 | -8.7 % |
| 2024Q3 | 113 | +8 | 12,652,037 | -4.6 % |
| 2024Q2 | 105 | +3 | 13,261,843 | +3.2 % |
| 2024Q1 | 102 | -12 | 12,853,012 | -2.5 % |
| 2023Q4 | 114 | 13,184,744 |
Institutional managers
100 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 5,456,666 | 3.8M $ | as of Mar 31, 2026 |
| Empery Asset Management, LP | 4,286,933 | 3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 4,200,000 | 2.9M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 3,713,761 | 2.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,703,955 | 2.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,705,390 | 1.9M $ | as of Mar 31, 2026 |
| Kalehua Capital Management LLC | 2,000,000 | 1.4M $ | as of Mar 31, 2026 |
| Burkehill Global Management, LP | 2,000,000 | 1.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,559,939 | 1.1M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,507,800 | 1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,280,390 | 886.5K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 1,180,081 | 817.1K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 1,072,911 | 743 $ | as of Mar 31, 2026 |
| Euclidean Capital LLC | 1,015,705 | 703.3K $ | as of Mar 31, 2026 |
| Raiffeisen Bank International AG | 1,000,000 | 620K $ | as of Mar 31, 2026 |
| Alphabet Inc. | 915,705 | 631.8K $ | as of Mar 31, 2026 |
| Mirador Capital Partners LP | 886,917 | 614.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 708,721 | 490.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 665,180 | 460.3K $ | as of Mar 31, 2026 |
| StepStone Group LP | 462,163 | 318.9K $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 361,969 | 250.6K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 348,268 | 241.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 310,654 | 215.1K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 308,772 | 213.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 268,505 | 185.9K $ | as of Mar 31, 2026 |
Declared shareholders of TENAYA THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Integrated Core Strategies (US) LLC and 3 others | 5.20 % | 11,581,565 | as of Aug 17, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding TENAYA THERAPEUTICS INC". https://titelia.com/en/stocks/tenaya-therapeutics-inc-US87990A1060